Stockscreener 앱 받기
2.36
11.85%
0.25
시간 외 거래:
2.38
0.02
+0.85%
Compugen Ltd 주식(CGEN)의 최신 뉴스
Can Compugen Ltd maintain sales growthEarnings Growth Summary & Stock Portfolio Risk Management - baoquankhu1.vn
Update Recap: Can Compugen Ltd stock continue upward trendPortfolio Value Report & Smart Money Movement Alerts - Bộ Nội Vụ
Targets Report: Will Compugen Ltd stock outperform tech sector in 2025July 2025 Volume & High Win Rate Trade Tips - Bộ Nội Vụ
Compugen shares jump after $65 million royalty monetization deal with AstraZeneca - MSN
Why Compugen Ltd. stock could benefit from AI revolutionRate Cut & Intraday High Probability Alerts - Улправда
Brokers Issue Forecasts for Compugen FY2025 Earnings - Defense World
HC Wainwright Estimates Compugen FY2025 Earnings - MarketBeat
Compugen (NASDAQ:CGEN) Coverage Initiated at HC Wainwright - Defense World
Compugen rises on royalty deal with AstraZeneca - MSN
Comparing Compugen (NASDAQ:CGEN) & Psyence Biomedical (NASDAQ:PBM) - Defense World
How buybacks impact Compugen Ltd. stock valueRate Hike & Capital Efficiency Focused Strategies - Улправда
Why Compugen Ltd. stock could rally in 2025Quarterly Portfolio Review & AI Optimized Trading Strategy Guides - Улправда
Will Compugen Ltd. stock benefit from infrastructure spending2025 Dividend Review & Low Volatility Stock Suggestions - Улправда
Is Compugen Ltd. stock a bargain at current levelsMoving Average Strategies & Expert-Backed Recommendations That Deliver - Улправда
H.C. Wainwright initiates coverage on Compugen stock with Buy rating By Investing.com - Investing.com Nigeria
Compugen (CGEN): HC Wainwright Initiates Coverage with 'Buy' Rat - GuruFocus
H.C. Wainwright initiates coverage on Compugen stock with Buy rating - Investing.com
This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
HC Wainwright & Co. Initiates Coverage of Compugen (CGEN) with Buy Recommendation - Nasdaq
Operating cash flow per share of Compugen Ltd. – TASE:CGEN - TradingView — Track All Markets
Will Compugen Ltd. stock benefit from sector rotationWeekly Profit Summary & Daily Growth Stock Tips - Улправда
Is Compugen Ltd. stock a defensive play in 2025Portfolio Gains Summary & Real-Time Volume Analysis Alerts - Улправда
Can Compugen Ltd. stock deliver strong Q4 earningsJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - Улправда
Compugen Secures $90 Million in a Strategic Royalty Monetization Deal with AstraZeneca - The Globe and Mail
Compugen (CGEN) Rises on Royalty Deal with AstraZeneca - GuruFocus
Compugen restructures AstraZeneca deal to boost cash coffers - גלובס
Compugen stock soars on $65 million AstraZeneca royalty deal By Investing.com - Investing.com Nigeria
Compugen stock soars on $65 million AstraZeneca royalty deal - Investing.com
Compugen Monetizes Portion of Cancer Treatment Future Royalties to AstraZeneca for Up to $90 Million - marketscreener.com
Compugen rises on royalty deal with AstraZeneca (CGEN:NASDAQ) - Seeking Alpha
Compugen monetizes portion of cancer drug royalties to AstraZeneca By Investing.com - Investing.com South Africa
Compugen monetizes portion of cancer drug royalties to AstraZeneca - Investing.com
Compugen monetizes portion of rilvegostomig future royalties to AstraZeneca for up to $90 million - marketscreener.com
Compugen Ltd. and Medimmune Limited Enter into Amendment Number 4 to the License Agreement - marketscreener.com
Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million - TradingView — Track All Markets
[6-K] COMPUGEN LTD Current Report (Foreign Issuer) | CGEN SEC FilingForm 6-K - Stock Titan
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million - marketscreener.com
Cancer immunotherapy royalty deal brings biotech up to $90M in funding - Stock Titan
Revenue per share of Compugen Ltd. – TASE:CGEN - TradingView — Track All Markets
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Compugen Presents Promising COM701 Analysis at ESMO 2025 - MSN
Compugen’s Former Head Reflects on Computational Discovery, Strategic Collaborations And AI - Citeline News & Insights
Compugen (NASDAQ:CGEN) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
4.73%
0.92%
자본화:
|
볼륨(24시간):